Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Thomas

Showing results (171-180 of 398) with videos related to

Pageof 40
Sort By:
Clinical Science (London, England : 1979)|June 1, 1983
Growth characteristics of alpha-foetoprotein-secreting human hepatocellular carcinoma in athymic (nude) miceM F Bassendine, N A Wright, H C Thomas, et al.
Lancet (London, England)|November 10, 1984
Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulinA M Lever, A D Webster, D Brown, et al.
Gut|November 1, 1976
Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosisH C Thomas, R Holden, J V Jones, et al.
Health Technology Assessment (Winchester, England)|June 6, 2006
Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluationM Wright, R Grieve, J Roberts, et al.
Journal of Hepatology|June 1, 1987
Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigen displayJ A McDonald, S Harris, J A Waters, et al.
British Medical Journal (Clinical Research Ed.)|December 12, 1987
Treatment of thrombocytopenia with alfa interferonA M Lever, M G Brook, I Yap, et al.
Gut|June 1, 1985
Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitateC A Lee, P B Kernoff, P Karayiannis, et al.
Lancet (London, England)|March 9, 1985
Non-A, non-B hepatitis after intravenous gammaglobulinA M Lever, A D Webster, D Brown, et al.
Nature Genetics|September 1, 1997
Heterozygote advantage for HLA class-II type in hepatitis B virus infectionM R Thursz, H C Thomas, B M Greenwood, et al.
Hepatology (Baltimore, Md.)|November 1, 1990
Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting responseL J Scully, D Brown, C Lloyd, et al.
Pageof 40

Showing results (171-180 of 398) with videos related to

Sort By:
Pageof 40
Clinical Science (London, England : 1979)|June 1, 1983
Growth characteristics of alpha-foetoprotein-secreting human hepatocellular carcinoma in athymic (nude) miceM F Bassendine, N A Wright, H C Thomas, et al.
Lancet (London, England)|November 10, 1984
Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulinA M Lever, A D Webster, D Brown, et al.
Gut|November 1, 1976
Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosisH C Thomas, R Holden, J V Jones, et al.
Health Technology Assessment (Winchester, England)|June 6, 2006
Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluationM Wright, R Grieve, J Roberts, et al.
Journal of Hepatology|June 1, 1987
Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigen displayJ A McDonald, S Harris, J A Waters, et al.
British Medical Journal (Clinical Research Ed.)|December 12, 1987
Treatment of thrombocytopenia with alfa interferonA M Lever, M G Brook, I Yap, et al.
Gut|June 1, 1985
Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitateC A Lee, P B Kernoff, P Karayiannis, et al.
Lancet (London, England)|March 9, 1985
Non-A, non-B hepatitis after intravenous gammaglobulinA M Lever, A D Webster, D Brown, et al.
Nature Genetics|September 1, 1997
Heterozygote advantage for HLA class-II type in hepatitis B virus infectionM R Thursz, H C Thomas, B M Greenwood, et al.
Hepatology (Baltimore, Md.)|November 1, 1990
Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting responseL J Scully, D Brown, C Lloyd, et al.
Pageof 40